FDA Solidifies 2014 As Breakthrough Year With December Drug Approval Rush
Executive Summary
FDA hit high notes with new drug and therapeutic biologic approvals in 2014, turning in an 18-year high total of 41 novel agents – more than 20% with “breakthrough” therapy status – but the agency’s continuing consistency in review performance is the underlying theme.